ACCEL Lite: ESC Congress 2021 Late Breaker: EMPEROR-Preserved

<p>In this interview, Jeroen Bax, PhD, MD, FACC; Stefan Anker, MD, PhD; and Sherry-Ann Brown, MD, PhD, FACC, discuss the ESC Congress 2021 late breaker EMPEROR-Preserved, which evaluates the effect of empagliflozin for risk of cardiovascular death and hospitalisation for patients with heart failure and a preserved fraction with and without diabetes. Like what you hear? Get 20 episodes a month with CME/MOC credit at <a href= "http://www.acc.org/ACCEL"><em>www.acc.org/ACCEL</em></a>.</p>